SCHEMBL30903594

SCHEMBL30903594

COCc1c(OC)cc2occ(-c3ccc(OC)cc3)c(=O)c2c1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.66
▸ CYP3A4 P08684 8/20 0.66
▸ KDM4E B2RXH2 7/20 0.66
▸ SMN1; SMN2 Q16637 7/20 0.66
▸ MAPT P10636 7/20 0.66
▸ KMT2A Q03164 6/20 0.66
▸ TP53 P04637 6/20 0.66
▸ RAB9A P51151 5/20 0.66
▸ HSD17B10 Q99714 5/20 0.66
▸ MEN1 O00255 5/20 0.66
▸ NPC1 O15118 4/20 0.66
▸ HPGD P15428 4/20 0.66
▸ CYP2D6 P10635 3/20 0.66
▸ CYP2C9 P11712 3/20 0.66
▸ CYP2C19 P33261 3/20 0.66
▸ NFKB1 P19838 2/20 0.66
▸ NFKB2 Q00653 2/20 0.66
▸ RELA Q04206 2/20 0.66
▸ MAOA P21397 2/20 0.66
▸ MAOB P27338 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18222927 1.00 ALDH1A1 (0.66) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT
SCHEMBL18222886 0.91 ALDH1A1 (0.65) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT
SCHEMBL30903609 0.91 ALDH1A1 (0.65) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT
SCHEMBL18222910 0.87 CYP3A4 (0.60) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT
SCHEMBL30903590 0.84 ALOX15 (0.69) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT
SCHEMBL18222903 0.84 ALOX15 (0.69) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT
SCHEMBL28469105 0.84 ALDH1A1 (0.67) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT
SCHEMBL18222917 0.82 ALDH1A1 (0.72) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT
SCHEMBL30903585 0.82 ALDH1A1 (0.72) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT
SCHEMBL26145339 0.81 KDM4E (0.85) ALDH1A1CYP3A4KDM4ESMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113185486-B Antitumor agent 3-aryl-4H-chromen-4-one for the treatment of cancer 肯塔基大学研究基金会 2024-05-10 — — CN disclosed
Send feedback